Canadian cannabis sales reached CAD$5.07 billion in 2023, a 12.2% increase over 2022, with growth attributed to consumers transitioning from the illicit market and market maturation after the legalization of adult-use cannabis in 2018. However, despite a stabilizing market and price trends, the industry still faces challenges from high excise taxes and competition with the illicit market.
According to Canadian government data on cannabis sales in 2023, the sector experienced a notable increase, reaching 5.07 billion Canadian dollars ($3.5 billion euros) in adult-use cannabis retail sales, a rise of 12.2% compared to the previous year.
For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.
As the Canadian cannabis market matures, it is experiencing a natural slowdown in growth rates, reflecting a period of stabilization after the initial surge following the legalization of adult-use cannabis in 2018. Brad Poulos, a professor of entrepreneurship at Metropolitan University of Toronto, noted to MJBiz that “the vast majority of legal cannabis sales growth comes from consumers transitioning from the illicit market.”
Despite the growth in legal cannabis sales, the illicit market still holds a significant share, estimated at about 40% by Mr. Poulos. Other projections place it at around 30%. Mr. Poulos believes that narrowing the gap between legal and illicit markets is largely due to the expansion of product formats and improved access to legal stores.
Consumer preferences for cannabis have evolved, and notable changes have been observed in product categories. Pre-rolled joints, in particular, have seen exceptional growth, capturing 31.4% of total sales in 2023, almost on par with dried cannabis flowers.
Furthermore, while cannabis prices have decreased across most categories, the rate of price compression has slowed compared to previous years. This trend indicates a certain stabilization of the cannabis market, with pre-roll prices remaining stable due to strong demand.
Monthly sales data reveal fluctuations in consumer behavior and market dynamics. Despite a general decline in sales until December, monthly sales experienced a resurgence, reaching 441.2 million Canadian dollars, an increase of 3.6% year-over-year. Ontario was the main driver of this growth, with a notable increase of 19.3% in sales in December.
Despite overall growth, the Canadian cannabis industry continues to face significant challenges. High excise taxes and the persistent presence of the illicit market are major obstacles to the growth and viability of the legal market. Additionally, the sector anticipates a legislative review of legalization, with uncertain outcomes for producers and retailers.
Looking ahead, industry experts predict continued growth in cannabis sales in Canada, albeit at a more moderate pace. Poulos estimates a potential growth of 10% in 2024, mainly due to the continued transition of consumers from the illicit market and the expansion of legal cannabis stores in underserved areas such as Quebec.
—
(Featured image by GRAS GRÜN via Unsplash)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…
A new California Department of Public Health report has come out with recommendations for THC…
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…